{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:31:22Z","timestamp":1793979082095,"version":"4.8.0"},"reference-count":19,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,6]]},"DOI":"10.20945\/2359-4292-2023-0229","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T12:23:46Z","timestamp":1723033426000},"source":"Crossref","is-referenced-by-count":5,"title":["Euglycemic diabetic ketoacidosis in a patient with new-onset type 1 diabetes following a ketogenic diet: a potential risk of a dangerous dietary trend"],"prefix":"10.20945","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8356-4463","authenticated-orcid":false,"given":"Burcak Cavnar","family":"Helvaci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1391-0647","authenticated-orcid":false,"given":"Beril Turan","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7826-9059","authenticated-orcid":false,"given":"Didem","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2501-935X","authenticated-orcid":false,"given":"Oya","family":"Topaloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7526-8827","authenticated-orcid":false,"given":"Bekir","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"key":"key20240807081444_B1","article-title":"Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma","volume":"2017","author":"Rawla","year":"2017","unstructured":"1. Rawla P, Vellipuram AR, Bandaru SS, Pradeep Raj J. Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma. Endocrinol Diabetes Metab Case Rep. 2017 Sep 4;2017:17-0081. doi: 10.1530\/EDM-17-0081.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"5866","key":"key20240807081444_B2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/bmj.2.5866.578","article-title":"Euglycaemic diabetic ketoacidosis","volume":"2","author":"Munro","year":"1973","unstructured":"2. Munro JF, Campbell IW, McCuish AC, Duncan LJ. Euglycaemic diabetic ketoacidosis. Br Med J. 1973 Jun 9;2(5866):578-80. doi: 10.1136\/bmj.2.5866.578.","journal-title":"Br Med J"},{"issue":"1","key":"key20240807081444_B3","doi-asserted-by":"crossref","DOI":"10.1186\/1758-5996-4-23","article-title":"Low carbohydrate diet in type 1 diabetes, long-term improvement and adherence: A clinical audit","volume":"4","author":"Nielsen","year":"2012","unstructured":"3. Nielsen JV, Gando C, Joensson E, Paulsson C. Low carbohydrate diet in type 1 diabetes, long-term improvement and adherence: A clinical audit. Diabetol Metab Syndr. 2012 May 31;4(1):23. doi: 10.1186\/1758-5996-4-23.","journal-title":"Diabetol Metab Syndr"},{"issue":"12","key":"key20240807081444_B4","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jada.2010.09.014","article-title":"The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults","volume":"110","author":"Franz","year":"2010","unstructured":"4. Franz MJ, Powers MA, Leontos C, Holzmeister LA, Kulkarni K, Monk A, et al. The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults. J Am Diet Assoc. 2010 Dec;110(12):1852-89. doi: 10.1016\/j.jada.2010.09.014.","journal-title":"J Am Diet Assoc"},{"issue":"6","key":"key20240807081444_B5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2337\/dc18-2316","article-title":"International Consensus on Risk Management of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors","volume":"42","author":"Danne","year":"2019","unstructured":"5. Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, et al. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors. Diabetes Care. 2019 Jun;42(6):1147-54. doi: 10.2337\/dc18-2316.","journal-title":"Diabetes Care"},{"issue":"1","key":"key20240807081444_B6","first-page":"84","article-title":"A Review of Ketogenic Diet and Lifestyle","volume":"119","author":"McGaugh","year":"2022","unstructured":"6. McGaugh E, Barthel B. A Review of Ketogenic Diet and Lifestyle. Mo Med. 2022;119(1):84-8. PMID: 36033148; PMCID: PMC9312449.","journal-title":"Mo Med"},{"issue":"2","key":"key20240807081444_B7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/20009666.2019.1583534","article-title":"Severe anion gap metabolic acidosis associated with initiation of a very low-carbohydrate diet","volume":"9","author":"Basnet","year":"2019","unstructured":"7. Basnet S, Tachamo N, Nazir S, Dhital R, Jehangir A, Donato A. Severe anion gap metabolic acidosis associated with initiation of a very low-carbohydrate diet. J Community Hosp Intern Med Perspect. 2019 Apr 12;9(2):165-7. doi: 10.1080\/20009666.2019.1583534.","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"3","key":"key20240807081444_B8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1573399812666160421121307","article-title":"Euglycemic Diabetic Ketoacidosis: A Review","volume":"13","author":"Modi","year":"2017","unstructured":"8. Modi A, Agrawal A, Morgan F. Euglycemic Diabetic Ketoacidosis: A Review. Curr Diabetes Rev. 2017;13(3):315-21. doi: 10.2174\/1573399812666160421121307.","journal-title":"Curr Diabetes Rev"},{"key":"key20240807081444_B9","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7074868","article-title":"Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis","volume":"2018","author":"Yu","year":"2018","unstructured":"9. Yu X, Zhang S, Zhang L. Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis. Int J Endocrinol. 2018 Oct 2;2018:7074868. doi: 10.1155\/2018\/7074868.","journal-title":"Int J Endocrinol"},{"issue":"5","key":"key20240807081444_B10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00228-020-03051-3","article-title":"Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review","volume":"77","author":"Bamgboye","year":"2021","unstructured":"10. Bamgboye AO, Oni IO, Collier A. Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review. Eur J Clin Pharmacol. 2021 May;77(5):651-7. doi: 10.1007\/s00228-020-03051-3.","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"key20240807081444_B11","article-title":"A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis","volume":"14","author":"Patel","year":"2022","unstructured":"11. Patel K, Nair A. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis. Cureus. 2022 Sep 27;14(9):e29652. doi: 10.7759\/cureus.29652.","journal-title":"Cureus"},{"issue":"5","key":"key20240807081444_B12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/jdi.12330","article-title":"Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet","volume":"6","author":"Hayami","year":"2015","unstructured":"12. Hayami T, Kato Y, Kamiya H, Kondo M, Naito E, Sugiura Y, et al. Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet. J Diabetes Investig. 2015 Sep;6(5):587-90. doi: 10.1111\/jdi.12330.","journal-title":"J Diabetes Investig"},{"key":"key20240807081444_B13","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8832833","article-title":"A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed","author":"Steinmetz-Wood","year":"2020","unstructured":"13. Steinmetz-Wood S, Gilbert M, Menson K. A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed. Case Rep Endocrinol. 2020, 2020 Aug 13;2020:8832833. doi: 10.1155\/2020\/8832833.","journal-title":"Case Rep Endocrinol"},{"issue":"1","key":"key20240807081444_B14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2337\/cd20-0019","article-title":"Euglycemic Diabetic Ketoacidosis in a Patient Prescribed Empagliflozin and a Ketogenic Diet: A Case of Misdiagnosed Type 1 Diabetes","volume":"39","author":"Hendrickson","year":"2021","unstructured":"14. Hendrickson AL, Ye XQ, Kalra SS, Franck AJ, Urbine D. Euglycemic Diabetic Ketoacidosis in a Patient Prescribed Empagliflozin and a Ketogenic Diet: A Case of Misdiagnosed Type 1 Diabetes. Clin Diabetes. 2021 Jan;39(1):121-123. doi: 10.2337\/cd20-0019.","journal-title":"Clin Diabetes"},{"issue":"1","key":"key20240807081444_B15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.aace.2020.11.009","article-title":"Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature","volume":"7","author":"Mistry","year":"2020","unstructured":"15. Mistry S, Eschler DC. Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature. AACE Clin Case Rep. 2020 Dec 28;7(1):17-9. doi: 10.1016\/j.aace.2020.11.009.","journal-title":"AACE Clin Case Rep"},{"key":"key20240807081444_B16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejogrb.2020.03.021","article-title":"Very restricted carbohydrate (ketogenic) diet: A rare cause of a recurrent hypoglycemic-euglycemic diabetic ketoacidosis in the pregnancy","volume":"248","author":"Yaron","year":"2020","unstructured":"16. Yaron M, Shalit R, Kreiser D, Cukierman-Yaffe T, Yoeli R. Very restricted carbohydrate (ketogenic) diet: A rare cause of a recurrent hypoglycemic-euglycemic diabetic ketoacidosis in the pregnancy. Eur J Obstet Gynecol Reprod Biol. 2020 May;248:257-8. doi: 10.1016\/j.ejogrb.2020.03.021.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9","key":"key20240807081444_B17","article-title":"Euglycemic Diabetic Ketoacidosis Precipitated by a Keto Diet: Importance of Dietary History in Diagnosis","volume":"12","author":"Shaikh","year":"2020","unstructured":"17. Shaikh S, Mohamed MM, Mujeeb A, Shaikh F, Harris B. Euglycemic Diabetic Ketoacidosis Precipitated by a Keto Diet: Importance of Dietary History in Diagnosis. Cureus. 2020 Sep 2;12(9):e10199. doi: 10.7759\/cureus.10199.","journal-title":"Cureus"},{"issue":"3-4","key":"key20240807081444_B18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1515\/jpem-2013-0497","article-title":"Diabetic euglycemic ketoacidosis in newly diagnosed type 1 diabetes mellitus during Ramadan fasting","volume":"28","author":"Bas","year":"2015","unstructured":"18. Bas VN, Uytun S, Torun YA. Diabetic euglycemic ketoacidosis in newly diagnosed type 1 diabetes mellitus during Ramadan fasting. J Pediatr Endocrinol Metab. 2015 Mar;28(3-4):333-5. doi: 10.1515\/jpem-2013-0497.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key20240807081444_B19","article-title":"Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis","volume":"2019","author":"Rafey","year":"2019","unstructured":"19. Rafey MF, Butt A, Coffey B, Reddington L, Devitt A, Lappin D, et al. Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis. Endocrinol Diabetes Metab Case Rep. 2019 Sep 27;2019:19-0087. doi: 10.1530\/EDM-19-0087.","journal-title":"Endocrinol Diabetes Metab Case Rep"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T12:24:02Z","timestamp":1723033442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/euglycemic-diabetic-ketoacidosis-in-a-patient-with-new-onset-type-1-diabetes-following-a-ketogenic-diet-a-potential-risk-of-a-dangerous-dietary-trend\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":19,"alternative-id":["10.20945\/2359-4292-2023-0229"],"URL":"https:\/\/doi.org\/10.20945\/2359-4292-2023-0229","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e230229"}}